GlaxoSmithKline Rumored To Be Interested In Keryx

Sierra World Equity Review wrote that GlaxoSmithKline (NYSE: GSK) was interested in the possible acquisition of Keryx Biopharmaceuticals Inc. (Nasdaq: KERX). Shares of GlaxoSmithKline added 19 cents to close at $44.22 while Keryx stock gained 76 cents to close at $7.19.GSK

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here